Resources

Resources for TK2d and mitochondrial diseases

There are several resources for you and your patients when it comes to diagnosing and managing TK2d and other mitochondrial diseases.


TK2d on-demand webinar (from live event May 2026)​

Join our expert speakers, Prof Caterina Garone (chair), Dr Cristina Domínguez-González, Prof Thomas Klopstock, Prof Felix Distelmaier and Prof Edoardo Malfatti to learn more about TK2d, an ultra-rare mitochondrial disease​.

This on-demand webinar features peer-to-peer discussions with internationally recognised experts on the evolving disease management landscape for people living with TK2d, a potentially life-threatening ultra-rare mitochondrial disease. Topics include the challenges of diagnosis, the role of genetic testing and the importance of timely referrals. ​


Patient Stories

Jared: Life beyond TK2d

Meet Jared, an aspiring science fiction writer with a master’s in quantum mechanics, and hear how he navigates his life beyond TK2d. Listen to his story.

Video Transcript

Jared Patient Testimonial Transcript

Connie: Misperceptions of TK2d 

Meet Connie and learn how writing has empowered her to reclaim her narrative and address society’s misperceptions about TK2d. Listen to her story. 

Video Transcript

Connie Patient Testimonial Transcript


TK2d Resources
UMDF logo

TK2d Information From UMDF

Explore information about TK2d from the UMDF.

ClinicalTrials.gov logo

Clinical Trial Information

Learn how to participate in a clinical study or connect with a relevant research opportunity.


Find out more

Learn About Genetic Testing

Genetic testing provides the definitive diagnosis of TK2d.1

Sign Up for More Information

Receive information from UCB about developments in TK2d and other mitochondrial diseases.


GL-DA-2600754 | Date of preparation: July 2026

This website is neither intended nor designed to record or report adverse events. If you have adverse events to report for a UCB product, please follow the current regulatory procedure in your country or click on the following link to access the contact page of the UCB corporate website where you can report adverse events to UCB local affiliate contacts, UCBCares or by completing the UCB AE webform.


‎ ‎
GL-DA-2600210 | Date of preparation: May 2026
© UCB Biopharma SRL, 2026. All rights reserved.